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A novel approach for microRNA 
in situ hybridization using locked 
nucleic acid probes
Isabella W. Paulsen1,2*, Michael Bzorek3, Jesper Olsen2,4, Birgitte Grum‑Schwensen1, 
Jesper T. Troelsen2 & Ole B. Pedersen1*
Identification of target tissue microRNAs (miR) using in situ hybridization (ISH), with digoxigenin‑
labeled locked nucleic acid (LNA) probes, is influenced by preanalytic parameters. To determine the 
best retrieval method for common microRNAs, a multiblock composed of paraffin‑embedded tonsil, 
cervix, placenta, and hyperplastic prostate tissue were included. Tissue were fixed in 10% formalin in 
a range of 5–144 hours (h). Cut sections (5 μm) from the multiblock were subjected to combinations of 
pretreatment procedures: variable periods of proteinase K (PK) digestion or Heat‑induced microRNA 
Retrieval (HmiRR) using target retrieval solution (TRS) pH 6.1 or 9, with or without enzymatic 
treatment (pepsin). Results for the overall categories: TRS pH 9 versus PK; p = 2.9e−23, TRS pH 9 
versus TRS pH 6.1; p = 1.1e−14, TRS pH 6.1 versus PK; p = 2.9e−03. A long fixation time, resulted in the 
best microRNA preservation and staining intensity (long vs. short: p = 3.5e−47, long vs. moderate: 
p = 1.6e−44, moderate vs. short: p = 4.3e−16), was enhanced using HmiRR TRS pH 9 with or without 
pepsin providing high sensitivity and specificity. These observations conflict with other ISH techniques 
(e.g., messenger ribonucleic acid), which typically require shorter fixation periods, and therefore, 
further studies are warranted.
Over the past decade, noncoding RNA (ncRNA), including microRNAs, has become a hot research  topic1–3. 
Today, many different molecular methods are used for detection of microRNAs in tissue samples. Microarray 
and Next-Generation Sequencing (NGS) can be used for first phase validation. Quantitative RT-PCR is a popular 
tool for second phase validation analysis. For target validation of a given microRNA, tools such as luciferase 
reporter assays and northern blotting can be used for cell cultures. However, these methods only reveal the 
microRNA profile of the whole  sample4,5 and not where or from which cells the detected microRNAs originate. 
Therefore, to further elucidate the pathogenetic role or function of different microRNAs, it is of great interest to 
identify the specific location of microRNA expression in tissue. From that perspective, another molecular tool, 
microRNA in situ hybridization can be used to visualize and locate the site of expression in a formalin-fixed 
paraffin-embedded (FFPE) tissue  sample6,7.
In the field of ISH,  proteolysis8,9 or proteinase K  treatment10,11 is often recommended for retrieval of specific 
nucleic acid sequences in FFPE samples. However, the use of proteases can be difficult because the enzyme 
efficacy varies from batch to batch. Therefore, the concentration, digestion time and/or temperature must be 
adjusted and optimized each time ISH is performed. Excessive digestion of the tissue results in poor morphology 
and loss of microRNA. Several studies have shown that the appropriate buffers at high temperatures can also be 
used to recover DNA/RNA12,13, but only few reports support the use of Heat-induced microRNA Retrieval with 
LNA microRNA probes and  ISH14–16. Based on our own experience, performing microRNA-ISH using vendor 
recommended protocol settings is often troublesome (typically based on enzymatic digestion), labor intensive, 
and in the worst cases inaccurate. Therefore, the need for a ‘standardized’ system that can easily be implemented 
for both routine and research purposes is highly wanted.
The present study provides a “pretreatment test battery” model inspired by Taylor et al.17 for optimization 
of microRNA retrieval, with the aim of improving microRNA ISH assays of FFPE tissue using specific LNA 
 probes18. The pretreatment procedures were chosen based on our own experience for effective retrieval of anti-
gens (immunohistochemistry). In addition, we compared the morphology and signal intensity across tissues 
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after using different pretreatment procedures and variable fixation length/time in 10% buffered formaldehyde 
(formalin) solution.
Results
The first part of the protocol involves pretreatment, denaturation and hybridization. The second part of the 
protocol involves detection and visualization of microRNA expression in tissue. A paraffin multiblock with 
formalin-fixed tissue cores was prepared (Supplementary Figure S1). Kidney, placenta, prostate, tonsil and uterine 
cervical tissue were selected based on the known expression patterns of three microRNAs: miR-205-5p (squa-
mous epithelium), miR-145-5p (smooth muscle cells) and miR-126-3p (endothelial cells)19,20. A LNA scramble 
probe was included as negative control. No background staining was detected with LNA scramble probes and 
all probes revealed expected reaction patterns. The individual tissue cores in the multiblock sections serve as 
positive and negative controls for the respective LNA microRNA probes applied in this study, confirming the 
specificity of the staining protocol (Fig. 1).
Pretreatments were divided into proteolytic (Proteinase K and pepsin addition) and HmiRR with low or high 
pH buffer (TRS pH 6.1/TRS pH 9). For fixation of clinical samples, 1–3 days of fixation has been  proposed20, 
and 16–32 h has been suggested as the optimal fixation condition for obtaining high-quality  RNA21. To address 
optimal fixation conditions for microRNA ISH, tissues were fixed for different time intervals: short (5–24 h), 
moderate (30–76 h) and long (100–144 h).
Supplementary Tables S1–S3 display the mean rating of all pretreatments stratified into different fixation and 
tissue type groups. The mean ratings cover the given experimental combinations for the three LNA microRNA 
probes. As examples of the rating scale: negative (0) and 1 to 3, see Fig. 1.
The numeric rating data are aggregated, and the different scores are stratified according to tissue and fixa-
tion time to compare the different pretreatments (Table 1). The top four best pretreatments according to mean 
intensity were as follows: (1) TRS pH 9 treatment with pepsin for 5 min (mean = 1.8), (2) TRS pH 9 without 
additional pepsin (mean = 1.7), (3) TRS pH 9 with pepsin for 3 min (mean = 1.7), (4) proteinase K treatment 
for 2.5 min (mean = 1.4) (Fig. 2 and Table 1). These top four pretreatments were not statistically significantly 
different (Supplementary Table S4).
Comparing all the treatments with the best rated treatment (TRS pH 9 with pepsin for 5 min) revealed 
statistically significant differences from those with the lowest intensity including TRS pH 6.1 with pepsin for 
5 min (p = 5.0e−04), proteinase K for 20 min (p = 1.1e−20), proteinase K for 10 min (p = 1.0e−10), proteinase K 
for 5 min (p = 6.0e−05), TRS pH 6.1 (p = 1.3e−08) and TRS pH 6.1 with pepsin for 3 min (p = 2.1e−06) (Table 1).
By comparing different fixation times for the different tissues and categorizing fixation time into three groups 
(5–24 h, 30–72 h, and 100–144 h), we found that longer fixation periods led to higher signal intensity and better 
morphology across treatments. Thus, fixing tissues for 5–24 h, 30–72 h or 100–144 h resulted in mean intensity 
values of 0.64, 0.99, and 1.91, respectively (Table 2), across tissues and choices of treatment. Hence, long fixation 
(100–144 h) seems most efficient for microRNA preservation in tissue (Figs. 3, 4). Statistically significant differ-
ences were found among the following fixation categories: short versus long (p = 3.5e−47), short versus moderate 
(p = 4.3e−16) and moderate versus long (p = 1.6–44) (Table 2, Fig. 3). Figure 4 demonstrates how extension of the 
period for fixation enhanced probe staining intensity in tissues treated with HmiRR using TRS pH 9 (20 min in 
100 °C). In contrary, extension of the period for proteinase K treatment resulted in digestion of the tissue and 
as a result in poor probe staining intensity.  
When looking at time of fixation and type of treatment combined dividing them into three categories, namely: 
proteinase K (regardless of exposure time), HmiRR using TRS pH 6.1 (with or without pepsin) and HmiRR with 
TRS pH 9 (with or without pepsin) (Table 1), the highest score was obtained using HmiRR with TRS pH 9 (Global 
mean = 1.8), and thus, this seems to be the best treatment choice for permeabilization of FFPE tissues regardless 
of fixation time (Fig. 5). HmiRR with TRS pH 9 preserved morphology and had better intention was statistically 
significantly better than TRS pH 6.1 (p = 1.1e−14) and proteolysis (p = 2.9e−23). TRS pH 6.1 showed significant 
difference compared with proteolysis (p = 2.9e−03) at an alfa level of 0.02 (Table 2, Fig. 5).
In addition, the three LNA microRNA probes provided high specificity; no cross-hybridization of any of the 
three LNA microRNA probes was observed, and as expected, no staining of the LNA miR-205-5p probe was 
observed in kidney and placenta tissue (Fig. 1).
No cross-hybridization with the scramble LNA probe or background staining was observed (Fig. 1). Prevalent 
expression was found for miR-205-5p in the basal compartment of epithelial cells in the hyperplastic prostate, 
Figure 1.  In situ hybridization images of the rating scale. The pictures were taken at a magnification ×200 
or ×100 optic zoom with light microscopy. Blue color = nuclear staining (background staining). Brown 
color = probe staining. Rating is indicated with + (plus), hence, (−) = 0 and + to +  +  + (1 to 3). (a) Negative 
control, locked nucleic acid (LNA) scramble probe in prostate tissue. (b, c) absent probe staining of microRNA 
miR-205-5p (miR-205) in placenta- and kidney tissue. (d–f) staining of miR-205 in tonsil tissue. (g–i) staining 
of miR-145-5p (miR-145) in prostate tissue. (j–l) staining of miR-126-3p (miR-126) in tonsil or placenta tissue. 
(m–o) No cross-hybridization of the probes miR-205, miR-126 and miR-145 in cervical tissue: (m) miR-205 
expression in basal epithelia cells, (n) miR-126 in endothelia cells, (o) miR-145 smooth muscle cells around 
endothelia cells. Treatment: Heat-induced microRNA Retrieval (HmiRR) using target retrieval solution pH 6.1 
or 9 (H6.1 or H9). Enzymatic exposure: pepsin, Pe. Exposure time for proteolysis treatment is given in minutes 
and presented in (). Period of formalin fixation is given in hours, h. (a) H9 24 h, (b) H9 Pe(5) 24 h, (c) H9 Pe(5) 
140 h, (d) H9 120 h, (e) H6.1 Pe(5) 120 h, (f) H6.1 Pe(3) 120 h, (g) H9 144 h, (h) H9 24 h, (i) H6.1 Pe(3) 144 h, 
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tonsillar tissue, and cervix (both squamous epithelium); for miR-126-3p in endothelial cells of all tissue speci-
mens; and for miR-145-5p in smooth muscle cells in arterial walls (all specimens) and in stromal smooth muscle 
cells of a hyperplastic prostate (Fig. 1).
Consensus. Intraclass correlation coefficients (ICC) tests were performed for all probe staining intensities. 
The evaluations were performed independently by three raters resulting in an overall ICC of 0.75 indicating 
good interrater agreement. Hence, the closer the ICC is to one the better (Supplementary Table S5). By stratify-
ing agreement into three categories based on periods of fixation, 5–24 h, 30–76 h, and 100–144 h of fixation led 
to a ICC of 0.58, 0.64, and 0.78, respectively. Focusing on rating microRNA retrieval, proteolysis, HmiRR using 
TRS pH 6.1 with or without pepsin and HmiRR using TRS pH 9 with or without pepsin had an ICC of 0.71, 0.77 
and 0.75, respectively. All individual ICC for the ten treatments (ICC 1) and twelfth tissue-fixation categories 
(ICC 2) are displayed in Table 1.
Additional results and remarks. This protocol is a one-day protocol. If one prefers, after hybridization 
and stringent washes (Fig. 6), tissue sections can be stored overnight in Phosphate-buffered saline, PBS. Hence, 
continuing the protocol the following day (data not shown). Furthermore, all steps after stringent washes can be 
automatized using e.g. Dako Omnis IHC or other automated staining platform (Fig. 6). Additionally, according 
to preanalytic conditions, without postfixation with fixative 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide 
(EDC), HmiRR with pH buffers (TRS pH 6.1/9) is compatible with other ISH methods such as fluorescence 
ISH or staining methods using NBT/BCIP (ready-to-use tablets, Roche, cat. no. 11 697 471 001 or equivalent), 
Levamisole (Fluka, cat. no. 31742 or equivalent) and Nuclear Fast Red nuclear counterstain (Vector Laborato-
Table 1.  MicroRNA in situ hybridization, ISH, result table. The means of all three ISH experiments with 
the miR-205-5p, miR-145-5p and miR-126-3p probes, due to the given parameters, are presented within the 
largest square (main table). The upper horizontal bar shows the included tissue, and the numbers indicates the 
period of formalin fixation in hours. The first column from the left indicates pretreatment for permeabilization: 
proteinase K or Heat-induced microRNA Retrieval (target retrieval solution (TRS) pH 6.1 or TRS pH 9) with 
(w/) or without (w/o) pepsin addition. The second column shows exposure time for the given treatment. The 
additional number after the (+) presents enzymatic treatment w/ pepsin in minutes (min). The five columns 
to the right and four rows below the main table display statistics for the wide and longitudinal data: each test 
according to the ten pretreatments, regardless of tissue type and fixation period or the twelfth tissue-fixation 
categories. Mean 1 and 2 presents the mean across data points for the given pretreatment or tissue-fixation 
category SD 1 and 2, standard deviation. ICC 1 and 2, Intraclass correlation coefficients. p value 1 and 2, 
pairwise Wilcoxon signed-rank test relative to the best rated, assigned as (−). Global, the statistics are gathered 
into three categories: (1) Proteolysis; proteinase K (2.5–20 min), (2) TRS pH 6.1 (w/ and w/o pepsin) and (3) 
TRS pH 9 (w/ and w/o pepsin). Thus, the first number is the mean. The second is standard deviations. The 
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ries, cat. no. H-3403 or equivalent) (Supplementary Figure S2). Images of miR-205-5p probe staining in mam-
mary gland is also displayed in Supplementary Figure S2. Subsequently, ISH using HmiRR with an e.g. high pH 
buffer can be performed, if one wish to combine detection of a specific target microRNA with antigenic epitopes 
(immunohistochemistry), because permeabilization using HmiRR does not alter antigen epitopes as protease 
treatment does. A long fixation time provides better results for long-term storage of FFPE tissues. Permeabiliza-
tion and antigen retrieval with a pH buffer provide better detection conditions if one wishes to examine FFPE 
tissue samples after long-term storage.
Figure 2.  Boxplot of score distribution according to pretreatment of formalin-fixed paraffin-embedded tissues. 
Choice of pretreatment for permeabilization: Heat-induced microRNA Retrieval in Target Retrieval Solution 
(TRS) pH 6.1, TRS pH 9 or proteolysis with proteinase K. Exposure time for proteolysis treatment is given in 
minutes and presented in (). All scores are given regardless of tissue type, hence revealing the overall score of 
probe-staining effectivity. The x-axis shows type of treatment. The y-axis shows the mean score of the probe 
staining on a scale from 0 to 3, where 0 = no staining of the probe, and 3 is strong staining of the probe. The 
darker the color, the better the staining. The figure was constructed with the statistical software R.
Table 2.  Overall result table. The first column to the left presents the fixation time given in hour intervals 
and permeabilization categories: Proteolysis, Target Retrieval Solution (TRS) pH 6.1 and TRS pH 9. Second 
column, category of hour interval: short (5–24 h), moderate (30–76 h), long (100–144 h) and category of 
permeabilization: proteinase K or with (w/) or without (w/o) pepsin. Third column, Mean: the mean of 
the scores given in each category (Category). The fourth to the sixth column: a pairwise comparison of all 
categories using a Wilcoxon rank sum test. The fourth column and upper bar of column six and five displays 
the category to be compared (short, moderate or long). The numbers in column five and six display the p 
value of the given comparison of the categories. The p values were adjusted using the Benjamini and Hochberg 
procedure.




100–144 h Long 1.91 Long 3.5e−47 1.6e−44
Permabilization Category Mean p values Proteolysis TRS pH 6.1
Proteolysis Proteinase K 0.9
TRS pH 6.1 2.9e−03 –
TRS pH 6.1 w/w/o pepsin 1.1
TRS pH 9 w/w/o pepsin 1.8 TRS pH 9 2.9e−23 1.1e−14
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Discussion
Target microRNA preservation and accessibility are prerequisites for having a robust standardized microRNA-
ISH assay of formalin-fixed and paraffin-embedded tissue. Previous attempts to improve microRNA hybridization 
efficiency or to increase the sensitivity of the microRNA-ISH assay, especially for low abundance microRNA 
types, have emphasized the difficulties and the need for optimization when working with microRNA and ISH, 
regardless of whether commercial kits are  used8,22–24. Furthermore, not all commercial kits are compatible if one 
wants to demonstrate co-located proteins and microRNAs via direct or indirect  detection19,22.
There are different difficulties when working with microRNA and ISH. Formalin fixation conditions, such 
as concentration, time or temperature, influence successful detection of microRNA. Additionally, conditions 
for permeabilization differ between tissues; hence, some tissues undergo strong permeabilization due to lower 
binding accessibility of the probe to the microRNA. E.g., target microRNA in lymphocytes require a more gen-
tle pretreatment approach compared to detection of target microRNA in squamous epithelium. Moreover, the 
thickness of FFPE sections is an important parameter in choosing a sufficient microRNA retrieval method, and 
typically, more gentle pretreatment regimes are required when applied on thin  sections21.
Overdigestion is one of the main issues when working with protease treatment (Figs. 2, 4). Therefore, we 
used a “test battery approach” involving HmiRR to search for a pretreatment method that would generate robust 
assays results (Tables 1, 2). Our approach provides beneficial knowledge regarding preanalytical parameters. For 
reproducibility purposes, Supplementary Figure S3 demonstrates results for HmiRR with TRS pH 9 without 
enzymatic treatment from the optimization phase and from the final study setup.
Our study is based on LNA probe detection of microRNA, since this type of probe is the most frequently used 
probe for small RNA  ISH24, and was inspired by a study by Jørgensen et al.25. We showed that the ISH protocol 
could be conducted manually and could, if preferred, be semiautomated with the use of a Dako Omnis IHC and 
Figure 3.  Overall fixation strategies regardless of treatment. Categories: Short = tissue fixation for 5–24 h, 
Moderate = tissue fixation for 30–76 h, Long = tissue fixation for 100–144 h. All horizontal bars indicate 
statistical comparison of groups. All numbers above the horizontal bars are p values determined using a 
Wilcoxon signed-rank test. The figure was constructed with the statistical software R.
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ISH platform and completed within 24 h (Fig. 6). It is also possible to break the one-day workflow into a two 
half-day setup in which only 4 h are required per day.
By comparing different control LNA microRNA probes, duration of fixation, and different permeabilization 
strategies across tissues, the overall best performing method was HmiRR in TRS pH 9 regardless of additional 
pepsin treatment (Table 1). In addition, a long fixation time was found to better preserve the microRNAs within 
tissues (Table 2).
We used 5 µm thick tissue sections, which is twice as thick as the size (2.5 µM) normally used for immu-
nohistochemistry in the Department of Pathology, Zealand University Hospital, Roskilde, Denmark. A wide 
range of section thicknesses (4–40 µM) have been used in previous studies. None of the studies argues whether 
the chosen thickness of the paraffin sections matter, and none have tested the validity of different FFPE section 
thicknesses when working with  microRNA7,8,15,24–27.
Previous studies have used proteinase K for permeabilization, applying various concentrations and incuba-
tion times (temperature with enzyme)7,16,23,25,28. Masuda et al. demonstrated that proteinase K was effective for 
retrieval of RNA even in tissue exposed to a longer fixation time in formalin and in archival samples. Masuda 
et al. stated that both proteinase K and heat treatment (Tris-EDTA buffer, pH 7.0) were able to reverse chemical 
modifications induced by formalin. However, suggestions for heating modifications have been made with regard 
to pH dependence, higher temperatures and longer incubation  times28.
Nuovo et al. included an overnight in situ hybridization with labeled LNA probes and applied pepsin for 
pretreatment. Pepsin was preferred over proteinase K because the final outcome was less sensitive to the diges-
tion parameters (e.g., concentration of the enzyme, time, and temperature) and rarely caused overdigestion of 
 tissue8. Thus, low signal intensity after proteolysis treatment does not necessarily reflect low expression of the 
given microRNA but could also be a bias caused by the proteolysis treatment and lack of appropriate microRNA 
retrieval. Hence, examination of morphology is equally important. If proteolysis is insufficiently applied for too 
short a time, low signal intensity can be observed. However, the general recommendation by Nuovo et al. was 
to use proteinase K for permeabilization of tissue that has been fixed for days or weeks in formalin. Due to the 
overdigestion tendency of proteinase K, Nuovo et al. recommended that the digestion time be reduced to 5–10 
 min8. Similarly, a study by Jørgensen et al. recommended that proteinase K digestion be limited to 8  min25. How-
ever, we found proteinase K to be inferior to HmiRR across tissue types, especially with shorter fixation times.
In general, there is not a “standardized” procedure for applying enzymatic digestion for retrieval of microRNA, 
and the proteolytic step needs to be adjusted accurately according to both the length of fixation in formalin and 
Figure 4.  In situ hybridization. The images were taken at ×200 or ×100 (k) optic zoom with light microscopy. 
All tissues display miR-205-5p staining (brown staining). MiR-205-5p expression is restricted to basal epithelial 
cells. (a–c, e–g, i–k) display Heat-induced microRNA Retrieval using Target Retrieval Solution (TRS) pH 9 
(20 min at 100 °C) on prostate, tonsil and cervical tissue fixed in formalin for variable lengths of time (hours, 
h). Proteinase K (PK) digestion on tonsil tissue: (d) (2.5 min), (h) (5 min) and (l) (20 min). (a, e, i) display miR-
205-5p staining in cervical tissue fixed in formalin for 5–100 h. (b, f, j) display miR-205-5p staining in prostate 
tissue fixed for 24–144 h. (c–d, g–h, k, l) display miR-205-5p staining in tonsil tissue. (a, b, c) display tissues 
fixed for 5–24 h (Short fixation time). (e, f, g) shows tissues fixed for 30–72 h (moderate fixation time). (d, h–l) 
shows tissues fixed for 100–144 h (long fixation time).
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the type of tissue. In this regard, HmiRR seems more consistent but still requires that a pretreatment “test battery 
approach” be performed for each individual LNA microRNA probe to be optimized.
Other studies have employed HmiRR: Chaudhuri et al. (buffer pH = 6.4, for 40 min at 90 °C)15 and de Planell-
Saguer et al. (buffer pH = 6.0, for 10 min)16. The study by de Planell-Saguer et al. did not report whether exposure 
of tissue sections to longer pretreatment with citrate buffer at pH 6 provided better permeabilization than a 
10 min  exposure16. In our study, pretreament procedures based on TRS pH 6.1 gave inferior results compared 
to TRS pH 9-based procedures under the same boiling conditions: 20 min at 100 °C (Table 1).
In general, HmiRR, especially in TRS pH 9, achieved stable retrieval of microRNA across tissue types and 
fixation durations. Addition of pepsin for 3 min seemed equally effective. Increasing the pepsin exposure time 
to 5 min did improve staining intensity slightly but not statistic significant (Table 1, Supplementary Table S4). 
Surprisingly, a longer fixation time in formalin increased the intensity of the microRNA signal (Fig. 3, Tables 1, 
2). This observation conflicts with other studies in which ISH was applied for detection of RNA or DNA, showing 
that formalin fixation longer than 24–36 h can cause  problems21. One can speculate whether tissue exposed to 
a long formalin fixation time has the ability to retain a larger amount of diffusible small RNA transcripts (e.g., 
microRNA), providing better detection with ISH using short LNA probes, whereas larger probes are obstructed 
in targeting RNA/DNA sequences due to poor penetration through tissue exposed to long term fixation that 
leads to heavy cross-linking. This would be in line with our findings.
Several studies have found it beneficial to include a postfixation step with 1-ethyl-3-[3-dimethylaminopropyl] 
carbodiimide (EDC), EDC-hydrochloride (EDC-HCl) and 5-ethylthio-1H-tetrazole (5-ETT) in 1-methylimida-
zole buffer as a fixative water-soluble condensation reagent for better microRNA  crosslinking7,16,27. In contrast, a 
study by Jørgensen et al. was unable to improve the effect when adding the EDC  step25. Nevertheless, microRNA 
Figure 5.  Overall permeabilization strategies. Proteolysis covers all treatment with proteinase K, regardless of 
the duration of exposure (2.5–20 min). TRS pH 6.1 = Heat-induced microRNA Retrieval (HmiRR) with Target 
Retrieval Solution (TRS) pH 6.1 regardless of enzymatic treatment with pepsin. TRS pH 9 = HmiRR with TRS 
pH 9 regardless of enzymatic treatment with pepsin. All horizontal bars indicate statistical comparison of 
groups. The numbers above the horizontal bars are p values determined using a Wilcoxon signed-rank test. The 
figure was constructed with the statistical software R.
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fluorescence in situ hybridization (FISH) and conventional immunohistochemical (IHC) methods are incompat-
ible with ISH EDC  postfixation27. Therefore, a postfixation step was excluded in this approach.
This microRNA detection approach is applicable to fluorescence ISH staining or staining methods using 
NBT/BCIP (Roche), Levamisole (Fluka) and Nuclear Fast Red nuclear counterstain (Vector Laboratories) (Sup-
plementary Figure S2). Our approach, along with the finding that HmiRR in TRS pH 9 with or without pepsin 
addition retrieved the selected microRNAs in this study, is compatible with the vast majority of immunohis-
tochemical markers typically requiring Heat-Induced Epitope Retrieval (HIER) in the same buffer (TRS pH 
9). In fact, in immunohistochemical external quality assurance programs, such as UK NEQAS and NordiQC, 
virtually all markers assessed require HIER for optimal  performance29,30. This questions the use of proteases for 
retrieval of antigenic epitopes. Hence, setting up a combined method should be considered when working with 
microRNA detection.
Conclusion
HmiRR using TRS pH 9 with and without pepsin digestion provides robust results, with the best microRNA 
hybridization efficiency after long tissue fixation in formalin (range 100–144 h).
The method described herein provides a quick and easy protocol for detection of microRNA using ISH, 
even for an unexperienced user. This protocol can be run within one day or be divided into two half-work days. 
Additionally, it is possible to convert the workflow into a semi-automated protocol (Fig. 6). Although, HmiRR 
is stable and effective in our setting, different tissues and other microRNAs might require different approaches. 
This is why the battery test approach for different pretreatment strategies should be conducted every time a new 
test is optimized.
In the context of multiplexing involving detection of microRNAs, HmiRR using an appropriate buffer (e.g., 
TRS pH 9) might be more beneficial than proteolysis because only few antigenic epitopes (IHC) require enzy-
matic treatment for optimal performance.
Perspectives. The development of a robust protocol for microRNA ISH is likely to find wide application in 
both clinical- and research-related contexts. The use of a pretreatment test battery on a multiblock is only a part 
Figure 6.  Flowchart of microRNA in situ hybridization. The first four boxes at the top indicate the 
standard procedure, including tissue fixation, tissue embedding (paraffin embedding), cutting of slides and 
permeabilization. Permeabilization is achieved with proteolysis, Heat-mediated microRNA Retrieval (HmiRR) 
or a combination of HmiRR followed by enzymatic treatment with pepsin. After permeabilization, all slides 
were subjected to the same procedure: hybridization and stringent washes. Application of primary antibody, 
amplifier, and horseradish peroxidase (HRP) polymer and nuclear staining could be automatized on a Dako 
Omnis platform. To preserve the tests, all slides were mounted at the end.
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of the first validation process, identifying an optimal retrieval protocol for a given microRNA of interest and 
providing consistent signal intensity and reproducible results. Our results indicate that a longer fixation time in 
formalin provides better and more intense signals, which contradicts the findings of other studies and therefore 
warrants further investigation. However, once the optimal microRNA retrieval protocol has been identified, fur-
ther validation is needed, particularly for clinical purposes. Thus, if microRNA ISH can be applied for detection 
of disease-related microRNAs in both patient and normal tissues, that would be helpful to evaluate the method 
for future clinic application. Validation should be conducted using relevant clinical material displaying a wide 
range of microRNA densities (both negative and positive cases), and thereby, the sensitivity and specificity of the 
microRNA ISH protocol(s) can be accurately determined. Ideally, these results should be compared with those 
produced using other methods, such as cell lines known to express the target microRNAs, to confirm the robust-
ness and specificity of the optimized microRNA ISH assay.
Material and reagents
Equipment:
 1. Microtome, Microm HM 355S, Thermo Fisher
 2. Cold light source, SCHOTT KL200, SCHOTT AG
 3. Staining dish according to Hellendahl, DURAN, code no. SCOT233150002, DWK Life Sciences, VWR, 
VWR International, LLC.
 4. Staining jars, DURAN, Staining dishes acc. to Schiefferdecker, for up to 10 slides (with slide rack), code 
no. SCOT233160003, DWK Life Sciences, VWR, VWR International, LLC.
 5. Cover slips, thickness 1, D 263 M colorless borosilicate glass, 20 mm × 20 mm, code no. BB02000-
200A153MNT0, Thermo Scientific, Thermo Fisher Scientific
 6. FLEX IHC Microscope Slides, code no. K8020, Dako, Agilent Technologies, Inc.
 7. Metal tweezers, USBECK Laborgeräte, code no. 232-0088, VWR International, LLC.
 8. Dako Hybridizer, Dako, Agilent Technologies, Inc.
 9. Pasteur pipettes, disposable, LDPE, SEMADENI, code no. SEMA4271, VWR International, LLC.
 10. Fisherbrand Free-Standing Microcentrifuge Tubes with Screw Caps, code no. 12330433, Fisher Scientific, 
Thermo Fisher Scientific Inc.
 11. AccuBlock Digital Dry Bath, code no. D1302, Labnet International, Inc.
 12. Light Microscope, Nikon Eclipse 80i, Nikon Instruments, Inc.
 13. Microwave oven (MWO) with 6th Sense technology from Whirlpool
 14. DAKO Omnis ICH platform, Agilent Technologies, Inc.
Reagents for dewaxing and retrieval of microRNA:
1. Xylenes, histological grade, code no. 534056, Sigma-Aldrich, Inc.
2. Ethanol absolute ≥ 99.8%, AnalaR NORMAPUR ACS, Reag. Ph. Eur. analytiskt reagens, VWR Chemicals, 
code no. 20821.296, VWR International, LLC.
3. Ethanol 96%, code no. 1680643, Kemetyl A/S
4. EnVision FLEX Wash Buffer (20x) (pH 7.6) code no. K8007, DM831, Dako, Agilent Technologies, Inc. Tris-
buffered saline solution containing Tween 20, pH 7.6 (± 1)
5. EnVision FLEX Target Retrieval Solution (TRS), pH 9, (10x) code no. S2367, Dako, Agilent Technologies, 
Inc.
6. EnVision FLEX Target Retrieval Solution (TRS), low pH (pH 6.1), (50x), code no. K8005, DM829, Dako, 
Agilent Technologies, Inc.
7. MicroRNA ISH Optimization Kit 8 (FFPE), Exiqon Inc. code no. 339457, Qiagen: Proteinase K solution, 
Lyophilized, 12 mg, 1.25 mL, Exiqon Inc., Denmark
8. Pepsin solution, Ready-to-use, code no. ES-0001, ZytoVision GmbH, Germany
Hazard notes: perform steps with Xylene and Ethanol in a fume hood with appropriate protective gear. Wear 
protective gloves and eye/face protection, when working with proteinase K, pepsin solution, EnVision FLEX 
Wash Buffer (20×) and Target Retrieval solutions.
Reagents for hybridization:
1. Nuclease-free water (not DEPC-Treated), Invitrogen, code no. AM9932, Thermo Fisher Scientific Inc.
2. 2× miRNA ISH buffer 25 mL, code no. 90-012, Exiqon Inc., Denmark
3. Fixogum, code no. 11FIXO0050, MP Biomedicals
4. Phosphate-buffered saline (PBS) tablet, code no. 79382-50TAB, Sigma-Aldrich, Inc.
5. 20× Sodium-Saline Citrate (SSC) buffer stock solution, Ultrapure, code no. 15557044, Invitrogen, Thermo 
Fisher Scientific Inc.
6. MicroRNA ISH Optimization Kit 8 (FFPE), Exiqon Inc., code no. 339457, Qiagen: labeled Digoxigenin (DIG) 
Probe (miR-205-5p) conc. 25 µM. Scramble LNA Negative Control Probe (double DIG) 25 µM, 40 µL
7. Double labeled DIG Probe miR-126-3p, 10 nmol, Exiqon Inc., code no. 339112, Qiagen
8. Double labeled DIG Probe miR-145-5p, 10 nmol, Exiqon Inc., code no. 339112, Qiagen
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Hazard note: wear protective gloves, when working with DIG probes.
Reagents for probe detection:
1. Dako Pen, code no. S2002, Dako, Agilent Technologies, Inc.
2. EnVision FLEX Wash Buffer (20×) (pH 7.6), Tris-buffered saline solution containing Tween 20, pH 7.6 (± 1) 
code no. K8007, DM831, Dako, Agilent Technologies, Inc.
3. Mouse-anti-DIG, Ready-to-use, code no. AB-0001-30, ZytoVision GmbH, Germany
4. EnVision FLEX+ Peroxidase-Blocking Reagent, ready-to-use (15 mmol/L), code no. SM801, Dako, Agilent 
Technologies, Inc.
5. EnVision FLEX+ Mouse High pH, (Link), code no. K8002, DM804, Dako, Agilent Technologies, Inc.
6. EnVision FLEX Substrate Working Solution: 1 drop EnVision Flex DAB+ Chromogen (DM827) per 1 mL 
EnVision FLEX Substrate Buffer (SM803), Dako, Agilent Technologies, Inc.
7. Nuclease-free water (not DEPC-Treated), Invitrogen, code no. AM9932, Thermo Fisher Scientific Inc.
8. EnVision FLEX+ Haematoxylin, (Link), code no. K8008, SM806, Dako, Agilent Technologies, Inc.
9. PERTEX, mounting medium, Leica Microsystems, code no. LEIC811, VWR International, LLC.
Hazard note: if probe detection steps are not automatized, perform these steps in a fume hood with appropriate 
protective gear.
Methods
Study design. This protocol is for a one-day experiment. The first part of the protocol concerns pretreat-
ment, denaturation and hybridization. The second part of the protocol involves detection and visualization using 
an anti-DIG reagent (AB-0001-30, ZytoVision GmbH, Germany), a mouse linker (DM804, EnVision FLEX+, 
Dako, Agilent Technologies, Inc.), a detection system (K8002, EnVision FLEX+ Mouse High pH, Dako, Agi-
lent Technologies, Inc.) and the horseradish peroxidase (HRP) substrate 3,3-diaminobenzidine (DAB) (DM827, 
EnVision, Dako, Agilent Technologies, Inc.). Three probes with known hybridization patterns were chosen from 
optimization kits (339457, 339112, Exiqon Inc. Qiagen): miR-126-3p, miR-145-5p and miR-205-5p. These three 
microRNAs were used as positive controls. A scramble probe was used as a negative control (339457, Exiqon 
Inc. Qiagen). Kidney tissue was included in the multiblock as another negative control, because miR-205-5p is 
not expressed in the kidney, hence no expression of miR-205-5p was expected. The following expression patterns 
were expected; miR-126-3p is normally expressed in endothelial cells (all specimens), miR-145-5p in smooth 
muscle cells (all specimens) and miR-205-5p in squamous epithelium (predominantly the basal compartment) 
of the tonsil and cervix and in basal epithelial cells of the hyperplastic glands of the  prostate20,25,29. Because the 
aim was to design a protocol suitable for a routine laboratory workflow, RNAse Zap treatment of the equipment 
was not conducted. All experiments were performed in a normal standardized clean laboratory environment. 
The workflow is presented in Fig. 6. Images using this approach can be found in Figs. 1 and 4. Additionally, we 
verified that pH buffer treatment is compatible with other in situ hybridization methods: ISH and FISH (Sup-
plementary Figure S2). These applicable methods were beyond the aim of this study but have been emphasized 
as an issue  elsewhere27. Notable, the series of preanalytic treatment have been tested together once. For demon-
strating reproducibility, Supplementary Figure S3 displays images of HmiRR with TRS pH 9 without enzymatic 
treatment from the optimization phase of the study.
Preparation and pretreatment. All tissue specimens were fully anonymized, and consequently the study 
did not require scientific ethics approval. Fresh tissue samples from the cervix, kidney, tonsil, placenta and 
hyperplastic prostate were sliced into 10 × 10 × 3 mm pieces, fixed for different time periods in 10% buffered for-
maldehyde (formalin) solution (range 5–144 h) and processed into paraffin using standard procedures. A multi-
block was constructed by punching out relevant tissue cores (4 mm) from the paraffin-embedded tissue, and 
detailed information regarding fixation time can be seen in Supplementary Figure S1. The multiblocks were cut 
(5 µm), and slides were air-dried overnight, heated for 1 h at 60 °C, dewaxed in xylene (534056, Sigma-Aldrich, 
Inc.) (3 × 5 min), rehydrated through a graded alcohol (20821.296, VWR International, LLC., 1680643, Kemetyl 
A/S) series (99.9%, 96%, and 70% ethanol; each 3 × 2 min), and finally placed in nuclease-free water for 5 min. 
All glassware (staining jars and dishes (SCOT233150002, SCOT233160003, VWR International, LLC.), cover 
glasses (BB02000200A153MNT0, Thermo Fisher Scientific), and object glasses (K8020, Dako, Agilent Technolo-
gies, Inc.) and metal tweezers (232-0088, VWR International, LLC.) were used under the same hygiene standard 
applied in a hospital. Object glasses and cover glasses were taken from unopened packages.
The study included ten different combinations of microRNA retrieval methods to compare efficiency, robust-
ness and the quality of signal intensity.
Pretreatment with proteolysis. Proteinase K buffer (339457, Exiqon Inc. Qiagen) was diluted according 
to the manufacturer’s instructions and bought to 37 °C. Slides receiving proteolysis were treated for different 
intervals (range 2.5–20 min).
Pepsin was only used for slides receiving HmiRR. The pepsin solution was in a ready-to-use format (con-
centration not stated by the manufacturer). Slides were first subjected to heat treatment in an MWO for 20 min 
at 100 °C using an appropriate buffer, cooled for 10 min at room temperature (RT), and washed with DI water 
before application of the pepsin solution (ES-0001, ZytoVision GmbH, Germany) for 3 or 5 min. After incubation 
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with pepsin, all slides were washed for 5 min in PBS (79382-50TAB, Sigma-Aldrich, Inc.) and RNase-free water 
(AM9932, Thermo Fisher Scientific Inc.).
Pretreatment using Heat‑induced microRNA Retrieval. Slides were subjected to heat treatment in 
an MWO for 20 min at 100 °C using either TRS pH 6.1 (DM829, Dako, Agilent Technologies, Inc.) or TRS pH 9 
(S2367, Dako, Agilent Technologies, Inc.), cooled for 10 min at room temperature and washed for 5 min in PBS 
(79382-50TAB, Sigma-Aldrich, Inc.) and RNase-free water (AM9932, Thermo Fisher Scientific Inc.).
In situ hybridization, microRNA. A MicroRNA ISH Optimization Kit 8 (FFPE) (339457, Exiqon Inc. 
Qiagen) was used for in situ hybridization targeting the microRNA miR-205-5p. Probes for miR-126-3p and 
miR-145-5p were also included (339112, Exiqon Inc. Qiagen). Before use, all probes were denatured at 90 °C 
for 4 min. For the hybridization mix, the probe concentration was 120 nM in 1:1 nuclease-free water mixed 
with 2× microRNA ISH buffer. Hybridization mix (25 µL) was added onto each of the slides, which were then 
coverslipped (BB02000200A153MNT0, Thermo Fisher Scientific) and sealed with fixogum (11FIXO0050, MP 
Biomedicals). Slides were hybridized for 1.5 h at 55  °C using a hybridizer (Dako Hybridizer, Dako Agilent). 
The fixogum was removed and the slides were placed in 2× SSC (15557044, Thermo Fisher Scientific Inc.) at 
room temperature. All slides received stringent washes and were subjected to 2× SSC for 1 min at 57 °C, 0.2× 
SSC buffer for 20 min at 57 °C and 0.2× SSC for 5 min at room temperature. All SSC solutions were made fresh 
from a 20× SSC stock solution (15557044, Thermo Fisher Scientific Inc.). Finally, slides were placed twice in PBS 
(79382-50TAB, Sigma-Aldrich, Inc.) for 3 min.
Automated microRNA probe detection on a Dako Omnis IHC platform. After hybridization, the 
slides were loaded on a Dako Omnis IHC platform (wet program) (Dako Omnis, Agilent Technologies, Inc.), 
and probe reactions were detected using an anti-DIG antibody (AB-0001-30, ZytoVision GmbH, Germany) and 
visualized using a standard EnVision FLEX+/DAB system (DM827, SM803, Dako, Agilent Technologies, Inc.). 
Briefly, the slides were incubated with a mouse anti-DIG primary antibody (AB-0001-30, ZytoVision GmbH, 
Germany) for 30 min followed by blocking of endogenous peroxidase activity using EnVision FLEX Peroxidase-
Blocking Reagent (SM801, Dako, Agilent Technologies, Inc.) for 3 min. Reactions were detected using EnVi-
sion FLEX+ (DM804, K8002, Dako, Agilent Technologies, Inc.) and visualized using EnVision FLEX Substrate 
Working Solution (DM827, SM803, Dako, Agilent Technologies, Inc.) according to the recommendations pro-
vided by the manufacturer. The incubation temperature was 32 °C, and between all incubation steps, the slides 
were rinsed with wash buffer (DM831, Dako, Agilent Technologies, Inc.). Finally, the slides were incubated and 
counterstained with hematoxylin solution (SM806, Dako, Agilent Technologies, Inc.) for 3 min, rinsed in tap 
water, dehydrated using 3× 99% ethanol (20821.296, VWR International, LLC.) and permanently mounted using 
pertex (LEIC811, VWR International, LLC.).
Evaluation
The results were evaluated blinded for probe staining intensity and preservation of morphology and scored 
independently (Supplementary Figure S1 and Supplementary Table S1–S3). One person blinded all slides for 
three other raters to assess the results. For each probe, the grading scale was set by assigning the most successful 
test as the upper limit (numeric 3) and clear negative staining as the lowest value (0). Thus, tests equally suc-
cessful as the best rated can be assigned 3. Evaluation scale: 0 = no signal intensity; 1 = weak signal intensity; 
2 = moderate signal intensity; 3 = strong signal intensity. An asterisk * was given if the morphology of the tissue 
structures was reported impaired by a rater. Slides were examined with a light microscope (Nikon Eclipse 80i) 
with optical zoom at 100×, 200× and 400× magnification. Both the overall impression and the local microRNA 
expression site were taken into account.
Statistics. All statistical analyses and corresponding graphic outputs were conducted with the statistical 
software R version 4.0.2. The following packages were used: readxl version 1.3.1, dplyr 1.0.2, ggplot2 version 
3.3.2, irr version 0.84.1, ggthemes version 4.2.0, ggpubr version 0.4.0. Inspection of skewness was done by gen-
erating qq-plots for the quantiles using qqnorm() function (data not shown). A Shapiro–Wilk’s test was used for 
statistical testing for normality. To reduce skewness of data, data was log-transformed. For pairwise comparison 
of data, a non-parametric paired Wilcoxon rank sum test was used, with p value adjustment using the Benja-
mini–Hochberg procedure using False-discovery rate. The statistical alpha level was set according to Bonferroni 
correction depending on the amount of tests performed. Intraclass correlation coefficients (ICC) test was per-
formed using the icc() R function. For the icc() function: model was set to “twoway”, type were set to “consist-
ency” and unit were set to either “single” or “average”, dependent on the type of observation in the given test.
Consensus. The intensity for each probe (miR-126-3p, -145-5p and -205-5p) was assessed on the basis of 
seven gradings (0, 0.5, 1, 1.5, 2, 2.5, 3). ICC test was used to compare statistical agreement among raters. ICC test 
was performed for the intensity rating for fixation and for permeabilization. For all evaluations, an overall ICC 
test was calculated. Individually agreement on the ten pretreatments and the twelfth tissue-fixation categories 
was assessed.
Ethics. None of the authors has any conflicts of interest to declare. This project was conducted on anonymized 
patient material. The patient material consist of tissue biopsies taken from surgical specimens (cervix, kidney, 
placenta, prostate, and tonsil tissues). All specimens were surgically removed for treatment or diagnostic pur-
13
Vol.:(0123456789)
Scientific Reports |         (2021) 11:4504  | https://doi.org/10.1038/s41598-021-83888-5
www.nature.com/scientificreports/
poses. According to Danish law, completely anonymized left over material from diagnostic procedures can be 
used for research without patient consent or specific  approval31. This study received funding from The Danish 
Rheumatism Association (Project No.: R142-A4194 and R144-A4195).
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